JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
77 hedge funds and large institutions have $80.2M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $122M → $80.2M (-$41.4M)
Holders
77
Holding in Top 10
2
Calls
$57K
Puts
–
Top Buyers
| 1 | +$528K | |
| 2 | +$360K | |
| 3 | +$333K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$217K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$215K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$1.26M | |
| 3 | -$1.03M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$604K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$392K |